baber/WOPTO huggingface dataset:
Patent DE-69703972-T2 (DE)
Inventor: MILLER G
IPC: H05B3/36
Filed: 1997-04-18
Granted: 2001-06-13
Abstract: A method is provided for heating the surface of a tooling die. In the method, a heater element consisting of a fabric layer composed of conductive fibers is incorporated into the surface of a tooling die or mold. The heater element is attached to a power source, which energizes the element at prescribed intervals and temperatures to heat the surface of the tooling die.
Patent DE-69705366-T2 (DE)
Inventor: BELLOTTO GIORGIO
IPC: B60B19/10
Filed: 1997-03-03
Granted: 2002-05-16
Abstract: A wheel rim (10) for vehicles, comprising a front region (12) which is shaped so as to form, upon assembly, at least one NACA air intake (16) which is directed towards the corresponding brake and is adapted to extract the air adjacent to the corresponding brake from the inside outwards by suction induced by the centrifugal dynamics of the wheel rim.
Patent DE-69708128-T2 (DE)
Inventor: WALTER JOHN
IPC: B65D5/74
Filed: 1997-09-08
Granted: 2002-04-11
Abstract: The invention relates to a non-hinge lid smoking article pack, blank and print layout therefor which blank and print layout utilize a reduced amount of cartonboard and have reduced cartonboard waste from the print layout arrangement. Attempts to maximize interdigitation of blanks is proposed, whereby a saving of about 10% or more of cartonboard usage over a conventional hinge-lid pack can be achieved.
Patent DE-69720601-T2 (DE)
Inventor: TUNC DEGER C
IPC: A61B17/86
Filed: 1997-06-09
Granted: 2004-01-29
Abstract: Processes are set forth for forming high strength thermoplastic polymer bone fixation devices used, for example, in orthopedic surgery, where "strength" is quantified in terms a given device's pullout strength, tensile modulus, shear strength and breaking torque strength. Products of the aforementioned process are contemplated by the invention as well, with both "bioabsorbable" devices, for example, screws which are absorbable in an animal body and do not need to be removed after the bone in which they are inserted has healed; and non-bioabsorbable devices being described. <IMAGE>
Patent DE-69722933-T2 (DE)
Inventor: WAGNER M
IPC: B01D46/52
Filed: 1997-04-25
Granted: 2004-05-13
Abstract: Fluted filter media includes filter material having a plurality of flutes formed therein having alternating ends of adjacent flutes closed to force fluid through filter material. A first embodiment of the filter media includes tapered flutes which have the open ends of the flutes larger in cross-section than the closed flutes, wherein the upstream open flutes converge toward the downstream end and the upstream closed end flutes diverge toward the downstream end. A second embodiment includes filter media which is asymmetric formed with dissimilar upstream and downstream flute cross-sections with larger flute openings to the upstream side of the filter. A third embodiment includes filter media with an upstream edge crushed to improve flow at the upstream edge. A fourth embodiment includes filter media with the upstream sealing material recessed from the upstream edge for reducing effects from blockages at the upstream edge of the filter.
Patent DE-69725984-T2 (DE)
Inventor: CUINET JEAN-LOUIS
IPC: G04B27/02
Filed: 1997-05-16
Granted: 2004-05-06
Abstract: Crown setting device for an alarm setting crown and/or a time setting crown in an analog wristwatch uses a rotatable top ring mounted on the watch case, having gear teeth on its underside which mesh with gear teeth on the crown(s) to rotate the crown(s). This serves to set the time and/or alarms with less time and effort than conventional crown setting. Preferably involute gear teeth are used, but a simple version employs the conventional crown knurling as "teeth".
Patent DE-69803883-T2 (DE)
Inventor: KINDON NICHOLAS
IPC: C07D491/044
Filed: 1998-11-18
Granted: 2002-09-19
Abstract: The invention relates to new pharmaceutically active compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.
Patent DE-69807218-T2 (DE)
Inventor: WILSON ALASTAIR
IPC: B65D17/40
Filed: 1998-05-19
Granted: 2002-12-19
Abstract: A full aperture easy open end having a central panel, a circumferential score and a tab riveted to the central panel so that its nose is positioned above the score. When the end is first opened, the score is broken along an arc having a specific chord length. The end is of metal having a grain which is aligned to a tangent at one end of the chord. In a preferred embodiment, this "grain tangent" is also at minimum score residual.
Patent DE-69810141-T2 (DE)
Inventor: GORDEEV SERGEY KONSTANTINOVITC
IPC: C09K3/14
Filed: 1998-09-03
Granted: 2004-03-11
Abstract: The present invention relates to a method for producing abrasive grains. According to the invention the method is characterised by the steps of manufacturing a polycrystalline body comprising diamond particles in a matrix of silicone carbide and silicon, and crushing the polycrystalline body into grains. The invention also relates to abrasive grains produced by the method.
Patent DE-69810851-T2 (DE)
Inventor: BICHSEL MARTIN
IPC: H04H1/00
Filed: 1998-06-19
Granted: 2004-01-22
Abstract: The amount of data produced in the process of recording even short hearing samples by means of a monitor (1) may be considerably reduced by effecting a normalization to a range of values D and a subsequent nonlinear mapping to a second, preferably smaller range of values W. The result may be stored in an electronic memory. Further preferred measures are the spitting of the hearing samples into e.g. 6 signals each of which contains a respective frequency band of the original signal, and the conversion of the original amplitude values into energy variation values with simultaneous low pass filtering. Preferably, all cited processing steps are performed by a signal processor (9). A continuous recording time of up to 14 days by a monitor in the form of a wristwatch can thus be attained with state-of-the-art technology. <IMAGE>
Patent DE-69819328-T2 (DE)
Inventor: HOHLBEIN J
IPC: A46B7/06
Filed: 1998-06-24
Granted: 2004-08-05
Abstract: A toothbrush having a bristle-bearing head divided into at least two sections is disclosed. The free end section, when unstressed, is normally biased to assume an angle of about 15 DEG  with respect to the other, to thereby define an articulated head. The two sections of the head have facing ends joined by a thin bridge or hinge section integral with the two head sections, the bridge or hinge forming a groove between adjacent head sections. The upper surface of the bridge section is substantially flush with the upper surface of the head (opposite to the bristle-bearing surface). The space between the two facing ends is filled with a soft elastomer of about 5 to about 30, preferably about 13 to about 30 Shore A hardness. This hinge construction defines an articulated head of limited flex motion, wherein, when utilized by the average adult brusher, who applies an average brushing force of 0.5 pounds, flexes to a substantially flattened position. According to a second aspect of the invention, each end of the groove terminates in a flange at its extreme outer edge, and the groove, including the flange, is filled with an elastomer, which, due to the presence of the flange, is resistant to peel stresses caused by flexing of the hinge or joint.
Patent DE-69820417-T2 (DE)
Inventor: WILLCOCKS A
IPC: A23G1/00
Filed: 1998-01-09
Granted: 2004-09-30
Abstract: Methods of making chocolates that minimize the dramatic increases in viscosity typically associated with tempered chocolate. The invention also relates to the ability to process chocolates at higher temperatures without the need to temper at low temperatures.
Patent DE-69901451-T2 (DE)
Inventor: CHEN Y
IPC: C07F7/28
Filed: 1999-06-11
Granted: 2002-12-12
Abstract: Ansa bis( mu -substituted) Group 4 metal and aluminum compounds comprising a single Group 4 metal atom and two aluminum metal atoms corresponding to the formula: wherein: L' is a  pi -bonded group, M is a Group 4 metal, J is nitrogen or phosphorus; Z is a divalent bridging group causing the complex to have an ansa structure, R' is an inert monovalent ligand; r is one or two; X independently each occurrence is a Lewis basic ligand group able to form a  mu -bridging ligand group, and optionally the two X groups may be joined together, and A' independently each occurrence is an aluminum containing Lewis acid compound that forms an adduct with the metal complex by means of the  mu -bridging groups, and optionally two A' groups may be joined together thereby forming a single difunctional Lewis acid containing compound, and a method of preparation comprising contacting a charge-neutral Group IV metal coordination complex having at least two Lewis basic groups with at least two molar equivalents of charge-neutral aluminum coordination complexes having Lewis acidic aluminum atoms such that at least two of the aluminum atoms of the aluminum coordination complexes bond to at least two of the Lewis basic groups of the Group IV coordination complex.
Patent DE-69911212-T2 (DE)
Inventor: STAMLER S
IPC: A61K38/41
Filed: 1999-07-09
Granted: 2004-07-15
Abstract: Herein it is shown that hemoproteins (e.g., Ascaris hemoglobin, myoglobin, flavohemoglobins) have NO-consuming and deoxygenase activities. The invention provides a method of reducing the concentration of oxygen and/or nitric oxide in a mammal. The method of the invention comprises administering a therapeutically effective amount of a hemoprotein having NO-activated deoxygenase activity or an enzymatically active fragment thereof to a mammal. The method can be used to treat a mammal having pathologically proliferating cells, such as a tumor. In one embodiment, the hemoprotein is administered to reduce the oxygen concentration of a tumor. In another embodiment, the hemoprotein is administered together with a cytotoxic agent to treat a mammal having a tumor. The invention also provides a method of enzymatically generating toxic reactive oxygen species in a mammal for therapeutic purposes. The method comprises administering a therapeutically effective amount of a hemoprotein to a mammal. The invention also provides a composition comprising a hemoprotein having deoxygenase activity or an enzymatically active fragment thereof and a physiologically acceptable carrier. In one embodiment, the composition further comprises a cytotoxic agent and/or a reducing agent. The invention further provides a method of treating a mammal infected with Ascaris sp., comprising administering to said mammal a therapeutically effective amount of an inhibitor of NO synthase. The NO-consuming activity of a hemoprotein (e.g., a flavohemoglobin) can be used in a treatment where constriction of blood vessels is desirable, or where it is otherwise desirable to reduce NO concentration, as in inflammation.
Patent DE-69914954-T2 (DE)
Inventor: GADDY L
IPC: C12P7/08
Filed: 1999-05-07
Granted: 2005-02-17
Abstract: Two novel anaerobic strains of <i>Clostridium ljungdahlii</i> are isolated from the contaminants with which they are associated in nature, and are useful in process for converting certain waste gases from industrial processes into useful products, e.g., ethanol.
Patent DE-69917858-T2 (DE)
Inventor: AFRIAT ISABELLE
IPC: A61Q19/00
Filed: 1999-07-30
Granted: 2005-06-09
Abstract: The present invention relates to the use of a silicone gum to stabilize ascorbic acid or one of its esters or salts in a topical composition and to novel compositions comprising these components and having a pH of from 4 to 7. These compositions can be used in the fields of cosmetology, dermatology and veterinary medicine.
Patent DE-69932626-T2 (DE)
Inventor: HUI SIEW KOK
IPC: G10L19/00
Filed: 1999-11-12
Granted: 2007-10-25
Abstract: A method of processing signals received from an array of sensors includes sampling and digitally converting the received signals. The digitally converted signals are processed to provide an output signal, the processing including filtering the signals using a first adaptive filter that enhances a target signal of the digitally converted signals and a second adaptive filter that suppresses an unwanted signal of the digitally converted signals, and processing the filtered signals in a frequency domain to further suppress the unwanted signal. The digitally converted signals are processed to determine a direction of arrival of the target signal, the processing including filtering the signals using a third adaptive filter.
Patent DE-69937444-T2 (DE)
Inventor: OKADA YUKIO
IPC: C12N15/54
Filed: 1999-02-16
Granted: 2008-08-28
Abstract: An isolated and purified nucleic acid comprising a gene specifically expressed in hop lupulin glands. Hops are dioecious, and only female plants bear cones, the lupulin glands of which contain secondary metabolic products which provide bitterness and flavor to beer. These secondary metabolic products contain some pharmacologically effective compounds. In order to breed a more useful cultivar of hops by manipulating the constituent of such useful secondary metabolic products relying on genetic engineering techniques, this invention provides an isolated and purified nucleic acid comprising a gene specifically expressed in hop lupulin glands. By using this nucleic acid, it is possible to develop a novel method for breeding hops with transformation techniques and molecular selection techniques. Furthermore, the present invention also provides a nucleic acid comprising the regulatory region for specifically expressing genes in lupulin glands. This nucleic acid can be used also for hop breeding.
Patent HU-E035667-T2 (HU)
Title: Combined chemical oxidation/assisted bioremediation of contaminants
Inventor: BOULOS NOEL
IPC: B09C1/10
Filed: 2005-05-26
Abstract: A method for the combined chemical oxidation/assisted bioremediation of contaminated materials, comprising contacting a contaminated material with at least one metal chelate and at least one peroxide compound.
Patent HU-E025507-T2 (HU)
Title: Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
Inventor: BERRY LEANNE
IPC: A61K47/48
Filed: 2009-03-10
Abstract: Combinations of the antibody-drug conjugate trastuzumab-MCC-DM1 and chemotherapeutic agents, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting tumor cell growth, and for treating disorders such as cancer mediated by HER2 and KDR (VEGFR receptor 1). Methods of using such combinations for  in vitro, in situ,  and  in vivo  diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
Patent TR-200002543-T2 (TR)
Inventor: CONFER WILLIAM LESTER
IPC: A61P31/04
Filed: 1999-03-02
Abstract: A lyophilized pharmaceutical composition is described which contains Sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1H-indol-4-yl]oxy]acetate, a Solubilizer, and a Stabilizer. Such compositions are storage stable and readily dissolve in aqueous medium to give injectable solution for treatment of sepsis, etc.
Patent TR-200003333-T2 (TR)
Title: Ensülin direngenliği ve hiperglisemi tedavisinde yararlı benzotiyofenler
Inventor: WROBEL JAY EDWARD
IPC: C07D413/10
Filed: 1999-05-10
Abstract: Bu bulus,ensülin direngenligine veya hiperglisemiye bagli metabolik bozukluklarin tedavisinde yararli olan formül (I)'e iliskin bilesikleri saglamakta olup Ar burada (a), (b) veya (c)'dir. A,B,C,D,E,X,Y,Z1 ve Z2 burada tanim bölümünde tarif edildigi gibidir veya bunlarin farmakolojik olarak kabul edilebilir tuzlaridir.
Patent TR-200103582-T2 (TR)
Title: Zeolit ihtiva eden zerrecik halinde deterjan bileşeni.
Inventor: BERTHOD DANIEL PIERRE MARIE
IPC: C11D3/12
Filed: 2000-05-26
Abstract: Tercihan 600-900 g/l kütle yogunluklu bir parçacik halinde, sifir-fosfatli çamasir deterjani tozu, en azindan 1:1 bir agirlik oraninda zeolit MAP ve zeolit A'yi ihtiva etmektedir. Toz, organik sürfaktan ve zeolit kurucu maddesini ihtiva eden en azindan iki iki farkli zerrecik halinde bileseni ihtiva edelimektedir. Tercihan püskürtülerek kurutulmus olmayan ve 550-99 g/l bir kütle yogunluguna sahip olan bir birincik zerrecik halinde bilesen zeoilt MAP'i ihtiva ederek, tercihan püskürtülerek kurutulmus olan ve 200-450 g/l bir kütle yogunluguna sahip olan bir iknici zerrecik halinde bilesen zeolit A ihtiva etmektedir.
Patent DE-60200499-T3 (DE)
Inventor: GANDEL PIERRE
IPC: G01L3/10
Filed: 2002-02-27
Granted: 2010-08-12
Abstract: A position sensor, designed in particular for detecting a steering column torsion, including a first magnetic structure including a plurality of magnets and a second magnetic structure including two ferromagnetic rings having a plurality of teeth and defining an air gap. At least a magneto-sensitive element is placed in the air gap. The first and second magnetic structures are respectively integral with two parts in relative rotation. The two ferromagnetic rings are nested and have each a substantially tubular part forming axially oriented teeth connected by a flux-closing zone, the detecting air gap being delimited by the flux-closing zones.
Patent DE-60302474-T3 (DE)
Inventor: ROUSSELIN GUY
IPC: F16K1/30
Filed: 2003-01-10
Granted: 2017-03-30
Abstract: The control tap (1) has a handwheel (4) that can be rotated in either direction, operating a valve (11) via a shaft with a regulating system in the form of two holes (109) of different sizes in the shaft and a third hole (25) in the body of the valve, linked to its outlet (5). The hand wheel operates in two stages - one in which it opens the valve and the other in which it regulates the outlet flow through the holes.
Patent DE-69133211-T3 (DE)
Inventor: MOSSA ALBERT
IPC: B01L3/00
Filed: 1991-11-29
Granted: 2008-09-25
Abstract: An apparatus and control system for performing automated polymerase chain reaction (PCT) comprises a sample block (12) having wells for holding sample tubes (10), a computer controller (20), heating (14,156) and cooling (34,40) elements and a temperature sensor (21). The computer controller (20) monitors the temperature of the sample block (12) over time to determine the temperature of the liquid samples (10) and adjust the heating or cooling applied to the sample tubes (10) in order to provide for an optimal or desired PCR procedure.
Patent DE-69503120-T3 (DE)
Inventor: MARTIN ULRICH
IPC: A61K38/49
Filed: 1995-03-22
Granted: 2003-08-14
Abstract: The invention involves thrombolytically effective compositions, especially pharmaceutical packaging units for use in treating a patient in need of thrombolytic therapy. Said patient normally undergo thrombolytic therapy by administration of an effective amount of a thrombolytically active protein. The pharmaceutical packaging unit contains a) an effective amount of a non-heparin anticoagulant for use in combination with said thrombolytically active protein and b) an information leaflet providing instructions for use of said non-heparin anticoagulant to allow administration of said anticoagulant in the form of at least one intravenous bolus injection.
Patent DK-1165404-T3 (DK)
Inventor: CONNOLLY JAMES PATRICK
IPC: B65D90/20
Filed: 2000-04-04
Granted: 2006-08-21
Abstract: An improved portable storage container comprises an exterior support frame (1) defining an interior space having an upper periphery and including upright members (3) spaced around the periphery of the interior space and horizontal elongate members (6) disposed about the upper periphery of the interior space, the elongate members (6) each extending along a corresponding side of a polygon. A flexible vessel (2) is arranged within the interior space. The container comprises elastic support means for the upper perimetral portion of the perimetral wall (8) comprising a plurality of strips (10) of elastic material, each extending over a corresponding elongate member (6) of the supporting frame (1), a first end portion (11) of each strip (10) being bonded in a first region of bonding to an inner face of the perimetral wall (8), and a second end portion (12) being bonded in a second region of bonding to an outer face of perimetral wall (8).
Patent DK-1342094-T3 (DK)
Inventor: JECKO BERNARD JEAN YVES
IPC: G01R31/00
Filed: 2001-11-28
Granted: 2004-10-18
Abstract: A device for electromagnetic characterization of a tested structure elevates, on a predetermined frequency band, distribution parameters of the structure and parameters characteristic of the spurious rays of the structure. The device includes an electric signal generator and an analyzer for analyzing the signal transmitted by the generator and signals reflected by the structure and signals transmitted by the structure. In addition, the electric signal generator is a pulsed signal generator whereof the spectrum is at least as broad as the predetermined frequency band, and the analyzer includes a filter for temporal filtering of the signals it receives, to eliminate spurious signals.
Patent DK-1358128-T3 (DK)
Inventor: STAMIRES DENNIS
IPC: C01F7/785
Filed: 2002-02-05
Granted: 2005-11-28
Abstract: This invention relates to a process for preparing a 3R1-type crystalline anionic clay comprising the steps of: a) preparing an aqueous precursor mixture comprising aluminum trihydrate or a thermally treated form thereof and a magnesium source, the magnesium source being milled before use or when present in the precursor mixture, b) aging the precursor mixture at temperatures in the range 30°-100° C. to obtain the crystalline clay product, and c) optionally shaping the product of step b). Milling of the magnesium source, either alone or in combination with the (thermally treated) aluminum trihydrate, results in a faster reaction and higher conversion to anionic clay. The resulting anionic clay can be obtained by simply drying the slurry retrieved from the reactor. There is no need for washing or filtering, and a wide range of ratios of Mg/Al in the reaction product is possible.
Patent DK-1443933-T3 (DK)
Inventor: ROBIN JEAN-PIERRE
IPC: A61K31/506
Filed: 2002-09-05
Granted: 2010-01-25
Abstract: The present invention concerns a method of treating chronic myelogenous leukemia, a related myeloproliferative disorder or a Ph-positive acute lymphocytic leukemia in a subject animal, comprising: 
(a) selecting or identifying an animal suffering from chronic myelogenous leukemia or a related myeloproliferative disorder and showing resistance or intolerance to treatment with STI571; and 
(b) administering to the animal homoharringtonine.  In a preferred embodiment, the animal is a human being.
Patent DK-1460893-T3 (DK)
Inventor: WANG LIN
IPC: B01J20/28
Filed: 2002-11-20
Granted: 2011-02-21
Abstract: Disclosed is an animal litter made from ingredients including plant meal, citrus residue, and a cohesiveness agent. The litter is provided in the form of discrete plural articles which tend to agglomerate when wetted.
Patent DK-1425389-T3 (DK)
Inventor: VAN DE WINKEL JAN G J
IPC: A61P35/00
Filed: 2002-08-23
Granted: 2012-01-30
Abstract: Isolated human monoclonal antibodies which specifically bind to IL-15 (e.g., human IL-15), and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced in a transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals, and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent DK-1497417-T3 (DK)
Inventor: KOSMATOPOULOS KOSTAS
IPC: C07K14/715
Filed: 2003-04-23
Granted: 2007-06-25
Abstract: Immunogenic peptide (I) comprising a T epitope presented by major histocompatibility complex Class I molecules and consisting of a segment of 8-11 consecutive amino acids from the antigen EphA2 is new.  An Independent claim is also included for polynucleotide (II) that encodes (I).